Israel Englander’s Takeda Pharmaceutical TAK Stock Holding History

Israel Englander’s Portfolio TAK Stock Details TAK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-97,800	Closed	-$1.52M	–	6365
2025 Q4	$1.52M	Hold	97,800	–	–	﹤0.01%	4175
2025 Q3	$1.43M	Buy	+97,800	New	+$1.45M	﹤0.01%	4338
2021 Q2	–	Sell	-89,400	Closed	-$1.63M	–	7091
2021 Q1	$1.63M	Buy	+89,400	New	+$1.61M	﹤0.01%	3725

Other funds holding TAK

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

BIP

Brandes Investment Partners La Jolla, California $14.3B AUM 23.11% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Israel Englander's TAK Position: Q2 2026 in Review

Israel Englander opened a new position in Takeda Pharmaceutical (TAK) in Q2 2026: 1,050,698 shares worth $16.8M. The stake represents 0.01% of the portfolio and ranks #1777 among its holdings. This is a return to the name: Israel Englander previously reported a position in TAK as recently as Q4 2025.

Israel Englander first reported a position in TAK in Q4 2018 and has held it in 28 quarters since. The position peaked at $92.7M in Q4 2023. 375 funds tracked by Wall St. Rank hold TAK as of Q2 2026.

Israel Englander held 1,050,698 shares of Takeda Pharmaceutical worth $16.8M as of Q2 2026.
Takeda Pharmaceutical was a new Israel Englander position in Q2 2026.
Takeda Pharmaceutical made up 0.01% of Israel Englander's portfolio in Q2 2026, its #1777 holding.
Israel Englander first reported a position in Takeda Pharmaceutical in Q4 2018 and has held it in 28 quarters since.
Israel Englander's Takeda Pharmaceutical position peaked at $92.7M in Q4 2023.
375 funds tracked by Wall St. Rank held Takeda Pharmaceutical as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.